Streetbeat News

Revenues

PSTG

Pure Storage (NYSE:PSTG) received mixed analyst ratings with a shift towards a more bullish outlook, as evidenced by 17 analysts' evaluations. The average 12-month price target for PSTG has been raised to $52.94, marking a significant increase from the previous target. Analysts from firms like Susquehanna, Needham, and Citigroup have adjusted their ratings and price targets, reflecting optimism about Pure Storage's future performance. Despite facing challenges in revenue growth and ROE, Pure Storage exhibits strong net margin and ROA, alongside prudent debt management.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 2:00 pm

FATE

Fate Therapeutics (NASDAQ:FATE) has received mixed analyst ratings over the past three months, with an average 12-month price target of $7.33, marking an 83.25% increase from the previous target of $4.00. Analysts from firms including B of A Securities, HC Wainwright & Co., Morgan Stanley, BMO Capital, Barclays, and Wedbush have updated their ratings and price targets, reflecting various perspectives on the company's performance and market potential. Despite the optimistic price targets, Fate Therapeutics faces challenges in revenue growth, profitability, and financial risk management, with significant declines in revenue and net margin, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 2:00 pm

AAPL

Wedbush's Dan Ives is optimistic about Apple Inc.'s (NASDAQ:AAPL) future in China despite current struggles, citing steady iPhone production and strong performance in other key markets. Ives highlights potential growth catalysts including AI announcements and a stronger iPhone upgrade cycle, maintaining an 'Outperform' rating with a $250 price target. Apple faces competition and geopolitical challenges in China but is taking steps like shifting manufacturing to India.

Portfolio Pulse from Rounak Jain

April 11, 2024 | 1:43 pm

RVSN

Rail Vision Ltd (NASDAQ:RVSN) has received an initial $1 million purchase order from a U.S.-based rail and leasing services company, as part of a contract that could total up to $5 million. The order is for Rail Vision's AI-based ShuntingYard products, set to be installed in Q3 of this year. This marks a significant step in Rail Vision's expansion in the U.S. market, with potential for up to $4 million in additional orders under the contract.

Portfolio Pulse from Adam Eckert

April 11, 2024 | 1:26 pm

FN

Over the past three months, Fabrinet (NYSE:FN) has been evaluated by 5 analysts, showing a mix of bullish to bearish sentiments. The average 12-month price target for FN is now $216.4, marking a 1.44% increase from the previous target of $213.33. Analyst actions include ratings adjustments and price target changes by firms such as JP Morgan, Needham, and Northland Capital Markets. Fabrinet's financial performance is strong, with notable revenue growth, high net margin, and effective debt management, positioning it well in the Information Technology sector.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 1:01 pm

WCC

Recent analyst evaluations of WESCO Intl (NYSE:WCC) show a mix of bullish and indifferent sentiments, with 6 somewhat bullish and 2 indifferent ratings in the last three months. The average 12-month price target for WCC has been adjusted to $176.38, marking a 4.66% decrease from the previous target of $185.00. Analysts from firms like Keybanc, JP Morgan, Oppenheimer, Baird, and RBC Capital have updated their ratings and price targets, reflecting a nuanced view of WCC's market performance and financial health. Despite facing revenue growth challenges and below-average profitability metrics, WESCO Intl's strategic positioning and analyst attention suggest a cautiously optimistic outlook.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 1:01 pm

SOUN

Analyst ratings for SoundHound AI (NASDAQ:SOUN) show mixed sentiments, with recent adjustments reflecting a more optimistic outlook. The average 12-month price target has risen to $6.58, up 23.68% from the previous $5.32. Analyst actions include both upgrades and downgrades, with notable raises from DA Davidson and Wedbush to $9.50 and $9.00, respectively. SoundHound AI's financials indicate strong revenue growth but challenges in profitability, debt management, and asset utilization.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 1:01 pm

COLL

Collegium Pharmaceutical (NASDAQ:COLL) has received mixed analyst ratings over the past three months, with a recent upward trend in price targets to an average of $39.75, indicating a 7.43% increase from the previous $37.00. Analysts from Needham, Truist Securities, and Piper Sandler have maintained or raised their ratings, reflecting positive market dynamics and company performance. Collegium's financial performance shows strong revenue growth, profitability, and efficient asset management, with a market capitalization below industry averages but impressive growth and net margins.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 1:00 pm

IMCR

Immunocore Holdings (NASDAQ:IMCR) has received diverse analyst ratings, with 8 analysts offering perspectives ranging from bullish to bearish in the last three months. The average 12-month price target for IMCR has been raised to $81.00, an 11.57% increase from the previous target of $72.60. Analysts from firms including Needham, JP Morgan, HC Wainwright & Co., Mizuho, Oppenheimer, and Canaccord Genuity have updated their ratings and price targets, reflecting a generally positive outlook on the stock. Immunocore's financial performance shows significant revenue growth but challenges in net margin, ROE, and ROA, with a sound debt management profile.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 1:00 pm

SYNX

Silynxcom has announced receiving its first order for its innovative in-ear headset system, marking a significant milestone for the company.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 12:35 pm